- Home
- BWAY vs UAMY Comparison
BWAY vs UAMY Comparison
Compare BWAY & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- UAMY
- Stock Information
- Founded
- BWAY 2003
- UAMY 1968
- Country
- BWAY Israel
- UAMY United States
- Employees
- BWAY N/A
- UAMY N/A
- Industry
- BWAY Medical/Dental Instruments
- UAMY Metal Fabrications
- Sector
- BWAY Health Care
- UAMY Industrials
- Exchange
- BWAY Nasdaq
- UAMY Nasdaq
- Market Cap
- BWAY 280.7M
- UAMY 316.8M
- IPO Year
- BWAY 2019
- UAMY N/A
- Fundamental
- Price
- BWAY $15.77
- UAMY $4.94
- Analyst Decision
- BWAY Strong Buy
- UAMY Strong Buy
- Analyst Count
- BWAY 2
- UAMY 5
- Target Price
- BWAY $18.00
- UAMY $3.60
- AVG Volume (30 Days)
- BWAY 79.0K
- UAMY 5.8M
- Earning Date
- BWAY 11-11-2025
- UAMY 11-11-2025
- Dividend Yield
- BWAY N/A
- UAMY N/A
- EPS Growth
- BWAY 515.14
- UAMY N/A
- EPS
- BWAY 0.11
- UAMY N/A
- Revenue
- BWAY $46,084,000.00
- UAMY $25,728,046.00
- Revenue This Year
- BWAY $339.49
- UAMY $209.07
- Revenue Next Year
- BWAY $21.74
- UAMY $98.95
- P/E Ratio
- BWAY $54.58
- UAMY N/A
- Revenue Growth
- BWAY 26.50
- UAMY 134.91
- 52 Week Low
- BWAY $7.70
- UAMY $0.49
- 52 Week High
- BWAY $16.25
- UAMY $5.13
- Technical
- Relative Strength Index (RSI)
- BWAY 67.06
- UAMY 64.45
- Support Level
- BWAY $15.32
- UAMY $4.30
- Resistance Level
- BWAY $16.25
- UAMY $5.00
- Average True Range (ATR)
- BWAY 0.59
- UAMY 0.37
- MACD
- BWAY -0.07
- UAMY -0.02
- Stochastic Oscillator
- BWAY 70.25
- UAMY 80.81
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.